Cresset Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Cresset Asset Management’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-918	Closed	-$38K	–	922
2022 Q3	$38K	Sell	918 -82	-8%	-$3.75K	﹤0.01%	863
2022 Q2	$42K	Sell	1,000 -500	-33%	-$23.2K	﹤0.01%	913
2022 Q1	$102K	Buy	1,500 +1,000	+200%	+$83.2K	﹤0.01%	938
2021 Q4	$61K	Hold	500	–	–	﹤0.01%	1101
2021 Q3	$70K	Hold	500	–	–	﹤0.01%	1088
2021 Q2	$137K	Buy	+500	New	+$126K	﹤0.01%	977

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return